Proteome Sciences PLC - ESG Rating & Company Profile powered by AI
This analysis of Proteome Sciences PLC uses intelligence from across the internet as well as from available documents by Proteome Sciences PLC. Full ESG analysis of Proteome Sciences PLC can be accessed by signing up for free. The webpage of Proteome Sciences PLC was assembled by All Street Sevva using proprietary artificial intelligence.
Proteome Sciences PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 2.7 and governance score of 8.0.
6.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
427 | Scancell Holdings PLC | 6.3 | High |
427 | Verastem Inc | 6.3 | High |
450 | Proteome Sciences PLC | 6.2 | High |
450 | Cannasouth Ltd | 6.2 | High |
450 | CareDx International AB | 6.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Proteome Sciences PLC have an accelerator or VC vehicle to help deliver innovation?
Does Proteome Sciences PLC disclose current and historical energy intensity?
Does Proteome Sciences PLC report the average age of the workforce?
Does Proteome Sciences PLC reference operational or capital allocation in relation to climate change?
Does Proteome Sciences PLC disclose its ethnicity pay gap?
Does Proteome Sciences PLC disclose cybersecurity risks?
Does Proteome Sciences PLC offer flexible work?
Does Proteome Sciences PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Proteome Sciences PLC disclose the number of employees in R&D functions?
Does Proteome Sciences PLC conduct supply chain audits?
Does Proteome Sciences PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Proteome Sciences PLC conduct 360 degree staff reviews?
Does Proteome Sciences PLC disclose the individual responsible for D&I?
Does Proteome Sciences PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Proteome Sciences PLC disclose current and / or historical scope 2 emissions?
Does Proteome Sciences PLC disclose water use targets?
Does Proteome Sciences PLC have careers partnerships with academic institutions?
Did Proteome Sciences PLC have a product recall in the last two years?
Does Proteome Sciences PLC disclose incidents of discrimination?
Does Proteome Sciences PLC allow for Work Councils/Collective Agreements to be formed?
Has Proteome Sciences PLC issued a profit warning in the past 24 months?
Does Proteome Sciences PLC disclose parental leave metrics?
Does Proteome Sciences PLC disclose climate scenario or pathway analysis?
Does Proteome Sciences PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Proteome Sciences PLC disclose the pay ratio of women to men?
Does Proteome Sciences PLC support suppliers with sustainability related research and development?
Does Proteome Sciences PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Proteome Sciences PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Proteome Sciences PLC involved in embryonic stem cell research?
Does Proteome Sciences PLC disclose GHG and Air Emissions intensity?
Does Proteome Sciences PLC disclose its waste policy?
Does Proteome Sciences PLC report according to TCFD requirements?
Does Proteome Sciences PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Proteome Sciences PLC disclose energy use targets?
Does Proteome Sciences PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Proteome Sciences PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for Proteome Sciences PLC
These potential risks are based on the size, segment and geographies of the company.
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.